SELEGILINE GENERICS ACCEPTED BY OVER 20 STATE DRUG FORMULARIES; FDA AD DIVISION SENDS LETTER TO STATE FORMULARIES EMPHASIZING EQUIVALENCE TO ELDEPRYL TABS
Selegiline generics have been accepted by at least 20 state drug formularies, including California, New York and Texas, despite an ongoing dispute between FDA and the manufacturer of Eldepryl regarding whether the generics have demonstrated bioequivalence to the Parkinson's disease drug.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth